^
Association details:
| Biomarker: | AR positive |
|---|---|
| Cancer: | Prostate Cancer |
| Drug: | pruxelutamide (GT0918) (Androgen receptor antagonist, TMPRSS2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
MP16-15: Metabolomic profiling to evaluate the pharmacodynamic of Proxalutamide, a novel androgen receptor antagonist
Published date:
05/15/2020
Excerpt:
Cell viability assay indicated that proxalutamide showed potent anti-proliferative effects on AR-positive cells but weak on AR-negative cells.
